Access to anti-retroviral drugs, female in Liberia
Liberia: Access to anti-retroviral drugs, female was 96.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, female in Liberia, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
In 2024, access to anti-retroviral drugs, female in Liberia stood at 96.0%. That is the highest value across all 25 years on record.
Compared with earlier readings it is up 18.5% on the previous year and up 336.4% over ten years.
Over the whole period, access to anti-retroviral drugs, female in Liberia peaked at 96.0% in 2024 and was at its lowest, 0.0%, in 2000.
That places Liberia 14th out of 141 countries with data for 2024, putting it in the top 10%.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, female in Liberia, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2005 | 0.0% | — |
| 2006 | 2.0% | — |
| 2007 | 3.0% | +50.0% |
| 2008 | 5.0% | +66.7% |
| 2009 | 7.0% | +40.0% |
| 2010 | 11.0% | +57.1% |
| 2011 | 14.0% | +27.3% |
| 2012 | 16.0% | +14.3% |
| 2013 | 20.0% | +25.0% |
| 2014 | 22.0% | +10.0% |
| 2015 | 23.0% | +4.5% |
| 2016 | 27.0% | +17.4% |
| 2017 | 42.0% | +55.6% |
| 2018 | 47.0% | +11.9% |
| 2019 | 52.0% | +10.6% |
| 2020 | 63.0% | +21.2% |
| 2021 | 68.0% | +7.9% |
| 2022 | 78.0% | +14.7% |
| 2023 | 81.0% | +3.8% |
| 2024 | 96.0% | +18.5% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 1.7% | 0.0% | 7.0% | 10 |
| 2010s | 27.4% | 11.0% | 52.0% | 10 |
| 2020s | 77.2% | 63.0% | 96.0% | 5 |
Countries ranked near Liberia
More gender data for Liberia
- Child population (UN estimates and projections) 2,348 (2030)
- Child population (UN estimates and projections) (0-14), annual growth 0.9574 % change on previous year (2030)
- Population 4,018 (2030)
- Working-age population (UN estimates and projections) 4,018 (2030)
- Population (UN estimates and projections), annual growth rate 2.52 % change on previous year (2030)
- Age population, age 00, female, interpolated 81,391 (2025)
- Age population, age 00, male, interpolated 83,748 (2025)
- Age population, age 01, female, interpolated 79,207 (2025)
- Age population, age 01, male, interpolated 81,337 (2025)
- Age population, age 02, female, interpolated 77,744 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in Liberia?
- Access to anti-retroviral drugs, female in Liberia was 96.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in Liberia?
- The highest recorded value was 96.0% in 2024.
- What is the lowest access to anti-retroviral drugs, female recorded in Liberia?
- The lowest recorded value was 0.0% in 2000.
- How does Liberia rank for access to anti-retroviral drugs, female?
- Liberia ranks 14th out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, female rising or falling in Liberia?
- Over the last ten years it is up 336.4%. The long-run trend across the full record is volatile.
- Where does this Liberia data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.